{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:29:48Z","timestamp":1793413788950,"version":"4.5.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/humupd\/dmx017","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T15:18:46Z","timestamp":1497885526000},"page":"560-579","source":"Crossref","is-referenced-by-count":349,"title":["GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type"],"prefix":"10.1093","volume":"23","author":[{"given":"C.B.","family":"Lambalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Huirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Toftager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Homburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"key\n\t\t\t\t20171012234600_dmx017C1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C4","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012234600_dmx017C5","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012234600_dmx017C6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C7","first-page":"49","article-title":"Agonist vs. antagonist in ICSI cycles: a randomized trial and cost-effectiveness analysis","volume":"10","year":"2005","journal-title":"Middle East Fertility Society Journal"},{"key":"key\n\t\t\t\t20171012234600_dmx017C8","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarianhyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilotstudy","volume":"50","year":"2005","journal-title":"J Reprod Med"},{"key":"key\n\t\t\t\t20171012234600_dmx017C9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in vitro fertilization","volume":"83","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C10","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.fertnstert.2014.03.047","article-title":"Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C12","first-page":"257","article-title":"Effect of antagonists vs agonists on in vitro fertilization outcome","volume":"31","year":"2004","journal-title":"Clin Exp Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5653\/cerm.2012.39.4.166","article-title":"Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: in vitro maturation, GnRH agonist, and GnRH antagonist cycles","volume":"39","year":"2012","journal-title":"Clin Exp Reprod Med"},{"key":"key\n\t\t\t\t20171012234600_dmx017C15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7827-10-33","article-title":"GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology","volume":"10","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00404-012-2522-0","article-title":"A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients","volume":"287","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/09513590802617762","article-title":"Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer","volume":"25","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C18","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization","volume":"89","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012234600_dmx017C19","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.fertnstert.2011.01.134","article-title":"A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders","volume":"95","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.fertnstert.2007.04.006","article-title":"The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"European and Middle East Orgalutran Study Group","year":"2001","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2005.08.017","article-title":"Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist\/FSH ovarian stimulation cycles","volume":"124","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","article-title":"Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART","volume":"281","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C27","first-page":"27","article-title":"Comparison of ovarian stimulation with recombinant FSH after 2nd phase protocols with GnRH analogs (I-Estradiol + Ganirelix versus II-Nafarelin)","volume":"7","year":"2003","journal-title":"J Brasileiro Reprod Assist"},{"key":"key\n\t\t\t\t20171012234600_dmx017C28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1472-6483(10)60976-5","article-title":"Luteal phase characteristics following GnRH antagonist or agonist treatment\u2014a comparative study","volume":"12","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C29","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon)","volume":"13","author":"The Ganirelix Dose-Finding Study Group","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C31","first-page":"18","article-title":"Efficiency of antagonist IVF cycle programming by estrogens","volume":"38","year":"2010","journal-title":"Gynecol Obstet Fertil"},{"key":"key\n\t\t\t\t20171012234600_dmx017C32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-012-2348-9","article-title":"IVF\/ICSI outcomes of the OHP plus GnRH agonist protocol versus the OHP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial","volume":"286","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","article-title":"A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.12.021","article-title":"GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial","volume":"185","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C36","year":"2011"},{"key":"key\n\t\t\t\t20171012234600_dmx017C37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist co treatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012234600_dmx017C38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"key\n\t\t\t\t20171012234600_dmx017C39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","article-title":"Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization","volume":"47","year":"2008","journal-title":"Taiwan J Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C40","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/humrep\/deh357","article-title":"Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF\/ICSI patients: antide and hormone levels","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C41","first-page":"1793","article-title":"GnRH antagonists","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200464030-00005","article-title":"Contemporary pharmacological manipulation in assisted reproduction","volume":"64","year":"2004","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20171012234600_dmx017C43","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/humrep\/del030","article-title":"Cetrorelix in an oral contraceptive pretreated stimulation cycle compared with buserelin in IVF\/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study","volume":"21","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C44","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH antagonists comparable to agonists for use in IVF","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C45","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/humrep\/15.11.2333","article-title":"Dose-finding study of triptorelin-acetate for the prevention of premature LH surge in IVF: a prospective, randomized, double blind, placebo controlled study","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C46","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","article-title":"Comparison of mild stimulation and conventional stimulation in ART outcome","volume":"281","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C48","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","article-title":"Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection","volume":"92","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI","volume":"38","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"key\n\t\t\t\t20171012234600_dmx017C50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5653\/cerm.2012.39.1.22","article-title":"Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"39","year":"2012","journal-title":"Clin Exp Reprod Med"},{"key":"key\n\t\t\t\t20171012234600_dmx017C51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10815-006-9036-2","article-title":"Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol","volume":"23","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012234600_dmx017C53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","article-title":"Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial","volume":"95","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study","volume":"25","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C55","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","year":"2010","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C57","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2004.12.037","article-title":"Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration","volume":"83","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09513590600702733","article-title":"Comparison of outcome of clomiphene citrate\/human menopausal gonadotropin\/cetrorelix protocol and buserelin long protocol--a randomized study","volume":"22","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C59","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fertnstert.2004.04.051","article-title":"A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol","volume":"82","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/09513590801893331","article-title":"Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients","volume":"24","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C62","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.fertnstert.2010.02.059","article-title":"Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors","volume":"94","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C63","first-page":"148","article-title":"ART outcomes in GnRH antagonist protocol (flexible) and long GnRH agonist protocol during early follicular phase in patients with polycystic ovary syndrome: a randomized clinical trial","volume":"16","year":"2015","journal-title":"J Reprod Infertil"},{"key":"key\n\t\t\t\t20171012234600_dmx017C64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12325-008-0028-8","article-title":"Comparison of GnRH agonists and antagonists in normoresponder IVF\/ICSI in Turkish female patients","volume":"25","year":"2008","journal-title":"Adv Ther"},{"key":"key\n\t\t\t\t20171012234600_dmx017C65","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C67","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2006.12.046","article-title":"GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"88","year":"2007","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C68","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/humrep\/des066","article-title":"GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study","volume":"27","year":"2012","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C69","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deh832","article-title":"GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/09513590.2012.665103","article-title":"A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates","volume":"28","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial","volume":"166","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C72","first-page":"1063","article-title":"Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol","volume":"17","year":"2012","journal-title":"J Res Med Sci."},{"key":"key\n\t\t\t\t20171012234600_dmx017C73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","article-title":"\u2018Mild\u2019 vs. \u2018long\u2019 protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial","volume":"31","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","article-title":"A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients","volume":"21","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1472-6483(10)61631-8","article-title":"Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction","volume":"9","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C76","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.fertnstert.2008.02.165","article-title":"Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40","volume":"91","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C77","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/oxfordjournals.humrep.a138123","article-title":"The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome","volume":"8","year":"1993","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C78","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2006.02.110","article-title":"Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial","volume":"86","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C79","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/humrep\/dei243","article-title":"Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C93","first-page":"CD006109","article-title":"Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques","volume":"20","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012234600_dmx017C80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012234600_dmx017C81","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012234600_dmx017C82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00404-008-0620-9","article-title":"Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"278","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OHP pretreatment in PCOS patients","volume":"282","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C84","first-page":"171","article-title":"GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran","volume":"9","year":"2011","journal-title":"Iran J Reprod Med"},{"key":"key\n\t\t\t\t20171012234600_dmx017C85","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","year":"2016","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012234600_dmx017C86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1472-6483(10)61868-8","article-title":"Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles\u2014a prospective, randomized study","volume":"7","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1472-6483(10)60420-8","article-title":"Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS","volume":"18","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012234600_dmx017C88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000362274","article-title":"Patients\u2019 preferences for gonadotrophin-releasing hormone analogs in in vitro fertilization","volume":"78","year":"2014","journal-title":"Gynecol Obstet Invest"},{"key":"key\n\t\t\t\t20171012234600_dmx017C89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2004.11.005","article-title":"A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy","volume":"120","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012234600_dmx017C90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10815-009-9300-3","article-title":"IVF\/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study","volume":"26","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171012234600_dmx017C91","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012234600_dmx017C92","doi-asserted-by":"crossref","first-page":"e106854","DOI":"10.1371\/journal.pone.0106854","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis","volume":"9","year":"2014","journal-title":"PLoS One"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/23\/5\/560\/19638352\/dmx017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T23:46:20Z","timestamp":1507851980000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humupd\/article\/23\/5\/560\/3965313\/GnRH-antagonist-versus-long-agonist-protocols-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":91,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,7,14]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmx017","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,7,14]]}}}